Top 9 robotics stocks to watch in 2026

By Stake Desk9 min read

Corporate capital spending sets the demand pace for automation hardware and software. When businesses pull back on investment, that pressure reaches across industrial, surgical and software automation alike.

Robotics companies build the machines and software behind automated work, from surgical systems guiding procedures in operating theatres to platforms that handle repetitive digital tasks across enterprise software. The nine stocks on this list cut across four sectors, with healthcare making up the largest group. Teradyne, Inc. ($TER) straddles both semiconductor test equipment and collaborative robotic arms, while UiPath, Inc. ($PATH) focuses on software-based automation rather than physical hardware.

How we built this list: We selected these companies based on their industry and relevance to the theme, then ordered them by market capitalisation. Prices are updated daily, and the list and supporting content are reviewed roughly every quarter. All data is sourced from Stake. This list isn't a recommendation and isn't ordered by suitability.

Company Name

Ticker

Share Price

Market Cap

In Watchlists

Tesla

TSLA

$345.82

$1.48T

510763

Texas Instruments

TXN

$263.75

$261.11B

2641

Thermo Fisher

TMO

$669.54

$255.19B

1240

Danaher

DHR

$220.36

$160.10B

580

Intuitive Surgical

ISRG

$399.05

$141.17B

4814

Boston Scientific

BSX

$41.98

$62.31B

971

Rockwell Automation

ROK

$361.93

$42.05B

1157

Teradyne

TER

$204.78

$35.51B

2375

UiPath

PATH

$10.96

$5.85B

4327

Past performance is not a reliable indicator of future performance.

Source: Stake market data. Figures in US$. Data updated as of 20 November 2026.

✅ Learn more: Top 10 U.S. data centre stocks to watch in 2026→

Looking to invest in Robotics stocks?

Sign up in minutes and get access to a CHESS-sponsored platform, where you can explore Robotics stocks and more.

1. Tesla ($TSLA)

TSLA 1-year price chart: down 12.5%, from US$395.23 to US$345.82. Range US$298.32 to US$489.88.

Price: US$345.82 · Daily: -7.6% · Market cap: US$1.48T · Sector: Consumer Discretionary · Industry: Cars & Auto Parts

Two business segments define Tesla, Inc. ($TSLA): automotive, and energy generation and storage. The automotive side manufactures and sells five consumer models – the Model 3, Y, S, X and Cybertruck – and also covers leasing, used car sales, insurance, paid supercharging and regulatory credit sales.

The energy segment handles solar system design, installation and leasing alongside battery storage products. The Powerwall is a residential battery unit. The Megapack serves utility-scale storage needs. Elon Musk leads the company's 134,785-strong workforce across both segments.

2. Texas Instruments ($TXN)

TXN 1-year price chart: up 72.0%, from US$153.33 to US$263.75. Range US$153.33 to US$332.28.

Price: US$263.75 · Daily: -7.7% · Market cap: US$261.11B · Sector: Technology · Industry: Semiconductors

Power management is central to what Texas Instruments Incorporated ($TXN) makes. Its Analog segment produces chips that convert, distribute, store and measure electrical energy, with a product range covering motor drives, amplifiers, data converters, interface components, clocks and sensors. That segment breaks into two lines: Power, which manages how electricity moves through a system, and Signal Chain, which handles the broader set of analogue functions. The portfolio is built to work across different voltage levels.

The Embedded Processing segment adds chips designed for specific tasks, where the mix of performance, power draw and cost can be adjusted depending on the application. CEO Haviv Ilan leads 33,000 employees across the company.

3. Thermo Fisher ($TMO)

TMO 1-year price chart: up 16.9%, from US$572.74 to US$669.54. Range US$438.34 to US$721.63.

Price: US$669.54 · Daily: -2.8% · Market cap: US$255.19B · Sector: Healthcare · Industry: Healthcare Equipment

Thermo Fisher Scientific Inc. ($TMO) makes the instruments, reagents and consumables that research labs and pharmaceutical companies use across drug discovery, vaccine production and clinical diagnostics. Its segments cover life sciences research tools, analytical instruments with supporting software, specialty diagnostic test kits and a broad catalogue of laboratory products for biopharma customers. $TMO also produces purification and filtration technologies used in drug and vaccine manufacturing. The company employs 125,000 people under CEO Marc Casper.

4. Danaher ($DHR)

DHR 1-year price chart: down 0.8%, from US$222.18 to US$220.36. Range US$161.91 to US$242.05.

Price: US$220.36 · Daily: -3.2% · Market cap: US$160.10B · Sector: Healthcare · Industry: Healthcare Equipment

Danaher Corporation ($DHR) makes the equipment, consumables and software that go into biological medicine research and manufacturing. Its Biotechnology segment covers bioprocessing and discovery tools – the kind used by pharmaceutical and biotech labs to develop and produce biological medicines. The Life Sciences segment adds instruments and software for studying DNA, RNA, proteins and cells at a molecular level.

The Diagnostics segment supplies clinical instruments and software used in patient testing, and $DHR also makes pulse oximetry and monitoring equipment for acute care settings. Under CEO Julie Sawyer Montgomery, the company employs around 58,000 people across all three segments.

Join 1M+ on Stake

Effortless investing in U.S. shares & ETFs

5. Intuitive Surgical ($ISRG)

ISRG 1-year price chart: down 27.7%, from US$552.23 to US$399.05. Range US$332.02 to US$592.85.

Price: US$399.05 · Daily: -2.0% · Market cap: US$141.17B · Sector: Healthcare · Industry: Healthcare Equipment

Intuitive Surgical, Inc. ($ISRG) builds robotic systems designed to assist surgeons during procedures, with its da Vinci platform at the centre of its business. That system pairs a surgeon's console with a patient-side cart and vision system, intended to support operations across general surgery, urology, gynaecology, cardiothoracic, and head and neck specialties.

Beyond the operating theatre, $ISRG also makes the Ion endoluminal system – a flexible, catheter-based platform designed for minimally invasive lung biopsies. That extends the company's reach into diagnostic procedures, not just surgery. Under CEO David Rosa, the company employs 17,021 people.

6. Boston Scientific ($BSX)

BSX 1-year price chart: down 56.5%, from US$96.60 to US$41.98. Range US$41.58 to US$101.58.

Price: US$41.98 · Daily: -2.3% · Market cap: US$62.31B · Sector: Healthcare · Industry: Healthcare Equipment

Boston Scientific Corporation ($BSX) develops and manufactures medical devices across two broad areas: MedSurg and Cardiovascular. The MedSurg side covers tools for diagnosing and treating gastrointestinal conditions, urological conditions ranging from kidney stones to prostate cancer, and devices for managing neurological movement disorders and chronic pain. Its Cardiovascular segment takes in interventional cardiology, electrophysiology, cardiac rhythm management and peripheral interventions.

Under CEO Mike Mahoney, $BSX employs around 59,000 people worldwide. The company's focus sits firmly on less-invasive technologies – devices designed to treat conditions internally rather than through open surgery.

7. Rockwell Automation ($ROK)

ROK 1-year price chart: down 1.8%, from US$368.70 to US$361.93. Range US$348.51 to US$495.08.

Price: US$361.93 · Daily: -5.5% · Market cap: US$42.05B · Sector: Industrials · Industry: Machinery & Vehicles

Rockwell Automation ($ROK) builds the hardware and software that runs industrial production lines. Its three segments cover the full picture: Intelligent Devices handles power, motion and safety components; Software & Control ties together automation platforms that merge IT and operational technology; Lifecycle Services provides consulting, cybersecurity and project delivery for companies running complex industrial programmes.

Chief executive Blake Moret leads a workforce of 26,000 people. The company's pitch – what it calls the Connected Enterprise – is essentially the idea that factory-floor systems and enterprise IT networks can speak the same language, reducing friction between production data and business decisions.

8. Teradyne ($TER)

TER 1-year price chart: up 31.4%, from US$155.90 to US$204.78. Range US$155.90 to US$483.84.

Price: US$204.78 · Daily: -10.0% · Market cap: US$35.51B · Sector: Technology · Industry: Semiconductors

Teradyne, Inc. ($TER) sits at an unusual intersection: the same company that makes equipment to test semiconductors also builds collaborative robotic arms and autonomous mobile robots. That split across hardware categories is baked into how $TER is structured, with Semiconductor Test, Robotics, and Product Test operating as distinct segments under one roof.

The Semiconductor Test segment makes the systems that check whether chips work before they ship – covering everything from storage to system-level testing. Product Test covers a wider spread of hardware: circuit-board inspection, wireless test systems, silicon photonics testing and defence and aerospace instrumentation.

The Robotics segment is where $TER connects most directly to the automation theme that runs through this article. Collaborative robotic arms are designed to work alongside people on assembly lines, while autonomous mobile robots handle movement and logistics tasks. Gregory Smith leads the company, which employs 6,600 people globally.

9. UiPath ($PATH)

PATH 1-year price chart: down 13.9%, from US$12.73 to US$10.96. Range US$9.38 to US$19.29.

Price: US$10.96 · Daily: -2.4% · Market cap: US$5.85B · Sector: Technology · Industry: Software & IT

UiPath, Inc. ($PATH) builds software that automates repetitive digital work – the kind of tasks that involve logging into applications, filling in forms, moving files or reading emails. Rather than physical robots, $PATH sells a platform that deploys what it calls a digital workforce: software agents that carry out those tasks autonomously or alongside human employees.

The UiPath Platform combines computer vision, user interface automation, API integrations and AI-based document understanding into a single workflow environment. Enterprises can use it to discover where automation makes sense, build it quickly, and run it at scale. The company describes this approach as agentic automation – meaning AI agents can execute and optimise complex business processes without constant human input.

Under CEO Daniel Dines, $PATH employs 3,981 people. Its focus is squarely on the enterprise software market, where businesses use the platform to handle high-volume, process-heavy work across functions like finance, HR and operations.

➡️ Top 10 AI stocks to watch in 2026→

Common questions

How do I invest in robotics stocks in Australia?

Every company in this list trades on U.S. exchanges, so you buy them through a share trading platform that provides access to U.S. markets. Shares are purchased in individual companies, priced in USD. Some investors approach the theme through robotics or automation-focused ETFs rather than individual stocks, though ETFs are a separate product from the companies covered here.

What are the key risks of robotics stocks?

Some of the key risks include competitive displacement – newer systems can erode an incumbent's position, and companies whose revenue is concentrated in a single product line carry more of that exposure. Several companies here make medical devices, which need a regulator's sign-off before reaching patients; delays can affect revenue timelines. Industrial automation spending tends to track capital expenditure cycles, meaning demand can soften when businesses pull back on investment. The AUD/USD exchange rate also affects what these U.S.-listed shares cost to buy and what any proceeds are worth in Australian dollars.

How do the types of companies in this list differ?

The list covers several distinct approaches to automation. $ISRG builds robotic-assisted surgical systems, while $BSX focuses on minimally invasive medical devices across surgery and cardiology. $ROK and $TER sit in industrial automation – factory-floor control systems, collaborative robotic arms and autonomous mobile robots. $PATH takes a different approach: its platform deploys software agents to handle repetitive digital tasks, with no physical machinery involved. $TXN supplies the analogue and embedded chips that underpin many automated systems, without building robots itself. $TSLA, $TMO and $DHR each bring automation into businesses that extend across electric vehicles, life sciences research and diagnostics.

More resources

✅ Top 10 quantum computing stocks to watch in 2026→

Disclaimer

Past performance is not a reliable indicator of future performance. When you invest, your capital is at risk. You should consider your own investment objectives, financial situation, and particular needs before making an investment decision. The value of your investments can go down as well as up and you may receive back less than your original investment. As always, do your own research and consider seeking appropriate financial advice before investing.

This is not personal financial advice nor a recommendation to invest in the securities listed. Any advice provided by Stake is of general nature only and does not take into account your specific circumstances. Trading and volume data from the Stake investing platform is for reference purposes only, the investment choices of others may not be appropriate for your needs and is not a reliable indicator of performance.

Please refer to hellostake.com/pricing for the fees that apply. When you trade securities priced in another currency, currency conversion fees may apply and movements in the exchange rate may affect your returns.


Portrait photo of Stake Desk, The freshest market insights at Stake.

Stake Desk

The freshest market insights

This article combines AI and human review from our analysts to bring you accurate, informative investing content at speed. For questions or suggestions, contact stakedesk@stake.com.au.


Subscribe

By subscribing, you agree to our Privacy Policy.

Explore Stake


Made in Australia

Sydney, Australia


Get the app

Scan QR code to download the app

Stakeshop Pty Ltd, trading as Stake, ACN 610 105 505, is an authorised representative (Authorised Representative No. 1241398) of Stakeshop AFSL Pty Ltd (Australian Financial Services Licence no. 548196). Stake SMSF Pty Ltd ACN 648 283 532 (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. For more information about SMSFs, see our SMSF Risks page. The Stake Accumulate Fund (ARSN 680 653 374) is issued by K2 Asset Management Ltd (ABN 95 085 445 094 AFSL 244 393), a wholly owned subsidiary of K2 Asset Management Holdings Ltd (ABN 59 124 636 782). The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services Guide, Terms & Conditions, Privacy Policy and Disclaimers before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

This information is being provided in connection with the Australian retail offer component of the initial public offering of shares of Class A common stock (“Shares”) in Anthropic, PBC (“Anthropic”) (“IPO”). The Australian retail offer is an offer of newly issued Shares by Anthropic (“Australian Retail Offer”) made under the Australian prospectus lodged with the Australian Securities and Investments Commission on 11 November 2026 (“Australian Prospectus”). This information does not form part of the Australian Prospectus, and anyone considering applying for Shares under the Australian Retail Offer should rely only on information in the Australian Prospectus and any supplementary or replacement Australian Prospectus. A copy of the Australian Prospectus is available on ipo.anthropic.com. Further information about Anthropic, the IPO, the Shares and the risks of investing in Anthropic is set out in the Australian Prospectus. Anyone considering applying for Shares under the Australian Retail Offer should read and consider the Australian Prospectus in full in deciding whether to acquire Shares under the Australian Retail Offer. Anyone who wants to acquire Shares under the Australian Retail Offer will need to complete the application form that accompanies the Australian Prospectus, in accordance with the process set out in the Australian Prospectus and any other instructions from their broker. Anthropic has applied to list its Class A common stock on the Nasdaq Global Select Market under the symbol “ANT”. Anthropic will not be applying for listing on the Australian Securities Exchange.

Us securities law disclaimer

A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission (“SEC”) but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This communication does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. No offer to buy the securities can be accepted and no part of the purchase price can be received until the registration statement has become effective, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to its acceptance after the effective date. The prospectus in the registration statement and other documents Anthropic has filed with the SEC include additional information about Anthropic and the offering. Investors may get these documents for free by visiting EDGAR on the SEC’s website at www.sec.gov. The registration statement (including the US prospectus) is available at www.sec.gov

Copyright © 2026 Stake. All rights reserved.